Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response

Acta Pharmacologica Sinica

Volumn 31, Issue 2, 2010, Pages 191-201

  Wang, Wei ^a,b   Wang, Jing ^b   Dong, Sheng Fu ^b   Liu, Chun Hong ^b   Italiani, Paola ^c   Sun, Shu Hui ^b   Xu, Jing ^d   Boraschi, Diana ^c   Ma, Shi Ping ^a   Qu, Di ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c CNR   (Italy)

^d Beijing Institute of Biological Products   (China)

Author keywords

Andrographolide; Antibodies; Cytokines; Immunomodulator; Macrophages

Indexed keywords

ANDROGRAPHOLIDE; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MANNOSE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; IMMUNOPHENOTYPING; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN CELL; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; BASE SEQUENCE; BLOTTING, WESTERN; DITERPENES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHOSPHORYLATION;

EID: 76949085146     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.205     Document Type: Article

References (33)

1. State Pharmacopoeia Committee. Chinese Pharmacopoeia. Beijing: Chemical Industry Press; 2005. p 189-190.
2. Kligler B, Ulbricht C, Basch E, Kirkwood CD, Abrams TR, Miranda M, et al. Andrographis paniculata for the treatment of upper respiratory infection: A systematic review by the natural standard research collaboration. Explore-Ny 2006; 2: 25-9.
3. Abu-Ghefreh AA, Canatan H, Ezeamuzie CI. In vitro and in vivo antiinflammatory effects of andrographolide. Int Immunopharmacol 2009; 9: 313-8.
4. Zhou J, Lu GD, Ong CS, Ong CN, Shen HM. Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation. Mol Cancer Ther 2008; 7: 2170-80.
5. Yu BC, Chang CK, Su CF, Cheng JT. Mediation of beta-endorphin in andrographolide-induced plasma glucose-lowering action in type I diabetes-like animals. Naunyn-Schmiedeberg's Arch Pharmacol 2008; 377: 529-540
6. Woo AY, Waye MM, Tsui SK, Yeung ST, Cheng CH. Andrographolide up-regulates cellular-reduced glutathione level and protects cardiomyocytes against hypoxia/reoxygenation injury. J Pharmacol Exp Ther 2008; 325: 226-35.
7. Sheeja K, Kuttan G. Modulation of natural killer cell activity, antibodydependent cellular cytotoxicity, and antibody-dependent complementmediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice. Integr Cancer Ther 2007; 6: 66-73.
8. Sheeja K, Kuttan G. Activation of cytotoxic T lymphocyte responses and attenuation of tumor growth in vivo by Andrographis paniculata extract and andrographolide. Immunopharmacol Immunotoxicol 2007; 29: 81-93.
9. Iruretagoyena MI, Tobar JA, Gonzalez PA, Sepulveda SE, Figueroa CA, Burgos RA, et al. Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse. J Pharmacol Exp Ther 2005; 312: 366-72.
10. Iruretagoyena MI, Sepulveda SE, Lezana JP, Hermoso M, Bronfman M, Gutierrez MA, et al. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther 2006; 318: 59-67.
11. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-69.
12. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008; 13: 453-61.
13. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000; 164: 6166-73.
14. Zhang X, Mosser DM. Macrophage activation by endogenous danger signals. J Pathol 2008; 214: 161-78.
15. Bowdish DM, Loffredo MS, Mukhopadhyay S, Mantovani A, Gordon S. Macrophage receptors implicated in the "adaptive" form of innate immunity. Microbes Infect 2007; 9: 1680-7.
16. Gazi U, Martinez-Pomares L. Influence of the mannose receptor in host immune responses. Immunobiology 2009; 214: 554-61.
17. Crow MK. Modification of accessory molecule signaling. Springer Semin Immunopathol 2006; 27: 409-24.
18. Jafarzadeh A, Zarei S, Shokri F. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates. Vaccine 2008; 26: 269-76.
19. Dong SF, Chen JM, Zhang W, Sun SH, Wang J, Gu JX, et al. Specific immune response to HBsAg is enhanced by beta-glucan oligosaccharide containing an alpha-(1-3)-linked bond and biased towards M2/Th2. Int Immunopharmacol 2007; 7: 725-33.
20. Gwinn MR, Vallyathan V. Respiratory burst: role in signal transduction in alveolar macrophages. J Toxicol Environ Health B Crit Rev 2006; 9: 27-39.
21. Varin A, Gordon S. Alternative activation of macrophages: Immune function and cellular biology. Immunobiology 2009; 214: 630-41.
22. Rao KM. MAP kinase activation in macrophages. J Leukoc Biol 2001; 69: 3-10.
23. Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 2003; 24: 358-63.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-8.
25. D'Anto V, Eckhardt A, Hiller KA, Spagnuolo G, Valletta R, Ambrosio L, et al. The influence of Ni(II) on surface antigen expression in murine macrophages. Biomaterials 2009; 30: 1492-501.
26. Gordon S. The macrophage: past, present and future. Eur J Immunol 2007; 37 Suppl 1: S9-17.
27. Qin LH, Kong L, Shi GJ, Wang ZT, Ge BX. Andrographolide inhibits the production of TNF-alpha and interleukin-12 in lipopolysaccharidestimulated macrophages: role of mitogen-activated protein kinases. Biol Pharm Bull 2006; 29: 220-4.
28. Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007; 6: 137-43.
29. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003; 73: 209-12.
30. Mora AL, Torres-Gonzalez E, Rojas M, Corredor C, Ritzenthaler J, Xu J, et al. Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am J Respir Cell Mol Biol 2006; 35: 466-73.
31. Brown BN, Valentin JE, Stewart-Akers AM, McCabe GP, Badylak SF. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009; 30: 1482-91.
32. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 2005; 23: 344-6.
33. Ma J, Chen T, Mandelin J, Ceponis A, Miller NE, Hukkanen M, et al. Regulation of macrophage activation. Cell Mol Life Sci 2003; 60: 2334-46.